105 DETECTION OF PLACENTAL LACTOGENS IN SWAMP BUFFALO BY RADIOIMMUNOASSAY TECHNIQUE

2009 ◽  
Vol 21 (1) ◽  
pp. 152
Author(s):  
N. V. Hanh ◽  
Q. X. Huu ◽  
N. T. Uoc ◽  
J. Sulon ◽  
N. M. Sausa ◽  
...  
Keyword(s):  
Placental Lactogen ◽  
Blood Collection ◽  
Fetal Plasma ◽  
Placental Lactogens ◽  
In Vivo Experiments ◽  
Domestic Ruminants ◽  
Pregnant Sheep ◽  
Heart Blood ◽  
Swamp Buffalo

Ruminant placental lactogens (PL) are members of the growth factor/prolactin (GH/PRL) family. They are synthesized by trophectodermal binucleate cells. There is evidence to suggest that PL is involved in control of fetal growth, through actions in both the maternal and fetal compartments, as well as in influencing mammary growth during pregnancy (Byatt JC et al. 1992 J. Anim. Sci. 70, 2911–2923). The structure and biology of PL have been studied in the cow, sheep, goat, human, and mice. The maternal concentration of PL is 100- to 1 000-fold greater in pregnant sheep and goats than in cows but no information exists about PL concentration in buffalo. The aim of the present study was to evaluate the ability to detect PL in buffalo fluids by using bovine PL antibody. Samples were collected in the slaughterhouse immediately after animal slaughter. The fetuses were measured after heart blood collection. A bPL RIA system was used to determine the bPL concentrations in the buffalo samples (Alvarez-Oxiley AV et al. 2007 Reprod. Fertil. Dev. 19, 877–885). The rbPL molecules were radio-iodinated with [125]I-Na by using the lactoperoxidase method (Thorell JI and Johansson BG 1971 Biochim. Biophys. Acta 251, 363–369). Concentrations of buffalo PL are presented in Table 1. In this RIA system, the minimum detected value was 0.068 ng mL–1, and the binding competition curves of bovine PL standard and buffalo fluids dilution using bovine PL antibody were paralleled in all kinds of samples. The lowest concentration was detected in allantoid fluid and the greatest concentration in fetal plasma (P < 0.05). Study of the biology of PL in buffalo has proved difficult because the concentration of PL in all buffalo fluids is very low. Furthermore, the research concerning buffalo PL function required in vivo experiments. Existing data suggest that at least the concentration of buffalo PL is different from cattle and other smaller domestic ruminants. In conclusion, our results provide preliminary information about concentrations of PL in buffalo fluids. Table 1.Concentration of placental lactogen in buffalo fluids This work was supported by a grant from the Belgian Technical Cooperation.

scholarly journals Characterization of Endogenous Retroviruses in Sheep

2003 ◽  
Vol 77 (20) ◽  
pp. 11268-11273 ◽  
Author(s):  
Nikolai Klymiuk ◽  
Mathias Müller ◽  
Gottfried Brem ◽  
Bernhard Aigner
Keyword(s):  
Endogenous Retrovirus ◽  
Ovis Aries ◽  
Endogenous Retroviruses ◽  
Open Reading Frames ◽  
In Vivo Experiments ◽  
Pregnant Sheep ◽  
Reading Frames

ABSTRACT Endogenous retrovirus (ERV) sequences have been found in all mammals. In vitro and in vivo experiments revealed ERV activation and cross-species infection in several species. Sheep (Ovis aries) are used for various biotechnological purposes; however, they have not yet been comprehensively screened for ERV sequences. Therefore, the aim of the study was to classify the ERV sequences in the ovine genome (OERV) by analyzing the retroviral pro-pol sequences. Three OERV β families and nine OERV γ families were revealed. Novel open reading frames (ORF) in the amplified proviral fragment were found in one OERV β family and two OERV γ families. Hybrid OERV produced by putative recombination events were not detected. Quantitative analysis of the OERV sequences in the ovine genome revealed no relevant variations in the endogenous retroviral loads of different breeds. Expression analysis of different tissues from fetal and pregnant sheep detected mRNA from both gammaretrovirus families, showing ORF fragments. Thus, the release of retroviruses from sheep cells cannot be excluded.

Placental lactogen and GH receptors in sheep liver: striking differences in ontogeny and function

1986 ◽  
Vol 251 (3) ◽  
pp. E328-E333 ◽  
Author(s):  
M. Freemark ◽  
M. Comer ◽  
S. Handwerger
Keyword(s):  
Binding Sites ◽  
Specific Binding ◽  
Fetal Liver ◽  
Late Gestation ◽  
Placental Lactogen ◽  
Ontogenetic Changes ◽  
Pregnant Sheep ◽  
Hepatic Receptors ◽  
Ovine Fetal

To determine whether changes in the relative biological potencies of ovine placental lactogen (oPL) and ovine growth hormone (oGH) during development derive from ontogenetic changes in the binding of these hormones to hepatic receptors, we have compared the binding of 125I-oPL and 125I-oGH to hepatic membranes from fetal lambs and pregnant sheep at mid- and late gestation and from postnatal sheep at 1 day to 7 mo of age. Specific high-affinity 125I-oPL binding sites in ovine fetal liver were detected as early as day 70 of gestation (term = 145 days), and the number of fetal 125I-oPL binding sites increased progressively throughout the latter half of gestation, reaching a maximum (11.2 fmol/mg protein) at 3-7 days before parturition. The potency of oPL (Kd 0.27 nM) in competing for 125I-oPL binding sites was 90 and 1,300 times greater than that of oGH and ovine prolactin, respectively. Although the number of fetal 125I-oPL binding sites increased throughout pregnancy, there was little or no specific binding of 125I-oGH noted in the fetus. Treatment of fetal liver membranes with 4 M MgCl2 did not enhance the subsequent specific binding of 125I-oGH, suggesting that the low specific binding of oGH did not result from occupation of hepatic receptors by endogenous circulating oPL or oGH. In contrast, MgCL2 treatment markedly increased the apparent number of fetal 125I-oPL binding sites, suggesting that oPL receptors in fetal liver are partly saturated in vivo by oPL.(ABSTRACT TRUNCATED AT 250 WORDS)

Rat placental hormones: attempts for identification of rat chorionic gonadotrophin and rat placental lactogen by in vivo experiments

1982 ◽  
Vol 99 (2) ◽  
pp. 288-294 ◽  
Author(s):  
Marco Tabarelli ◽  
R. Kofler ◽  
S. Schwarz ◽  
G. Wick
Keyword(s):  
Limit Of Detection ◽  
Chorionic Gonadotrophin ◽  
Placental Lactogen ◽  
Female Rat ◽  
Immature Female ◽  
Pregnant Rats ◽  
In Vivo Experiments ◽  
Rat Pituitary ◽  
Dose Dependent

Abstract. Rat placental extracts (rPE) were investigated in bioassays for their possible content of rat placental lactogen (rPL) and rat chorionic gonadotrophin (rCG). Luteotrophic and lactogenic activity of rPL was assessed by substitution of rats depleted of endogenous prolactin (Prl) by means of bromoergocryptine (BEC) in early pregnancy and the period of lactation, respectively. The abortifacient effect of a single dose of BEC on day 6 of pregnancy was abolished by rPE equivalent to 1 g rat placenta corresponding to 5 IU bovine Prl (NIH-P-B 2). Substitution was necessary until the evening of day 7 indicating that rPL does not take over the function of Prl before day 8. During lactation rPE reversed the lactation inhibiting effect of daily BEC treatment. In this assay rPL activity corresponded to 1.25–2.5 IU bPrl/g placenta. In order to test for the possible existence of rCG the gonadotrophic activity of rPE was assessed in immature female mice. No gonadotrophic activity was found when rPE equivalent to 1 g rat placenta was administered, whereas equivalents of 3 mg human placenta and 12 mg rat pituitary entailed a dose-dependent response. In this system 0.12 IU human chorionic gonadotrophin (hCG), which served as standard, was the minimal dose (MD) resulting in increased uterine weight. In addition rPE was tested in the immature female rat, where the limit of detection was found to be 0.5 IU hCG. Again no gonadotrophic activity was found in rPE. As the effects of rCG might have been restricted to its presumed target, the corpus luteum of pregnancy, rPE was also tested in pregnant rats depleted of endogenous luteinizing hormone (LH) by a single injection of anti-LH antibodies on day 10 of pregnancy. A MDof 0.5 IU hCG, which served as standard, prevented resorption of foetuses in all animals tested. rPE equivalent to 3.5 g rat placenta, rat pregnancy serum of day 18 and placental transplants could not substitute for endogenous LH.

High-density lipoproteins (HDL) stimulate placental lactogen secretion in pregnant ewes: further evidence for a role of HDL in placental lactogen secretion during pregnancy

1989 ◽  
Vol 120 (3) ◽  
pp. 423-427 ◽  
Author(s):  
A. Grandis ◽  
V. Jorgensen ◽  
L. Kodack ◽  
S. Quarfordt ◽  
S. Handwerger
Keyword(s):  
Physiological Role ◽  
Maternal Plasma ◽  
High Density ◽  
Placental Lactogen ◽  
High Density Lipoproteins ◽  
Indwelling Catheter ◽  
Fetal Plasma ◽  
Sds Page

ABSTRACT Previous studies from our laboratory showed that high-density lipoproteins (HDL) stimulate the release of human placental lactogen (PL) from cultured trophoblast cells from normal pregnant women. To determine whether HDL stimulates PL secretion in vivo, ovine HDL was infused over 2–5 min into 11 pregnant ewes (22 separate experiments) at 86–130 days of gestation via an indwelling catheter into the maternal jugular vein. The HDL, freshly prepared from the plasma of pregnant ewes by differential flotation ultracentrifugation, was greater than 99% purified as judged by SDS-PAGE. Plasma samples were obtained from the ewes before and at 0·5-h intervals for 6 h following the infusions and were assayed for PL by a specific homologous radioimmunoassay. The maternal infusion of HDL at doses of 302–784 mg (5·3–13·8 mg/kg body weight) stimulated significant increases in maternal plasma PL concentrations in six out of eight experiments (six ewes), and the infusion of 108–264 mg (1·9–4·6 mg/kg) stimulated plasma PL concentrations in two out of six experiments. In contrast, HDL at doses < 100 mg were without effect in eight experiments. The response to the HDL infusions was characterized by a sustained increase in plasma PL concentrations beginning 1·5–2·5 h after the infusions, reaching a maximum 274·2 ± 21·9% of the baseline value (P<0·001). In contrast, the maternal infusion of lipoprotein-free plasma proteins or saline had no effect on maternal plasma PL concentrations. Although the infusion of HDL into pregnant ewes stimulated an increase in maternal plasma PL concentrations, the infusion of HDL (0·8–22·0 mg/kg) into three fetuses in seven separate experiments had no effect on fetal plasma PL concentrations. The demonstration that HDL stimulates an increase in plasma PL concentrations in pregnant ewes strongly supports a novel physiological role for HDL in the regulation of PL secretion. Journal of Endocrinology (1989) 120, 423–427

scholarly journals Oxidized Forms of Glutathione in Peripheral Blood as Biomarkers of Oxidative Stress

2006 ◽  
Vol 52 (7) ◽  
pp. 1406-1414 ◽  
Author(s):  
Ranieri Rossi ◽  
Isabella Dalle-Donne ◽  
Aldo Milzani ◽  
Daniela Giustarini
Keyword(s):  
Oxidative Stress ◽  
Sample Pretreatment ◽  
Protein Carbonyls ◽  
Blood Collection ◽  
Slight Variation ◽  
In Vivo Experiments ◽  
Tert Butylhydroperoxide ◽  
Biomarkers Of Oxidative Stress

Abstract Background: Reduced glutathione (GSH) and its redox forms, glutathione disulfide (GSSG) and glutathionylated proteins (PSSG), are biomarkers of oxidative stress, but methodologic artifacts can interfere with their measurement. We evaluated the importance of correct sample handling during the preanalytical phase for GSH, GSSG, and PSSG measurement. Methods: We used human blood for in vitro experiments with oxidants [tert-butylhydroperoxide (t-BOOH), diamide, and menadione]. For in vivo experiments, we used rats in which we cannulated the jugular and femoral veins for both oxidant administration and blood collection. We measured GSH, GSSG, and PSSG with HPLC with or without sample pretreatment with N-ethylmaleimide (NEM) to prevent artifacts. We also measured malondialdehyde (MDA) with HPLC, and protein carbonyls (PCO) with spectrophotometric procedures. Results: When methodologic artifacts were prevented by pretreatment with NEM, GSSG results increased up to 3-fold over the basal concentrations, even in the presence of 5 μmol/L t-BOOH or diamide and 20 μmol/L menadione. PSSG increased by ∼50% at 20 μmol/L t-BOOH or diamide and at 50 μmol/L menadione. PCO and MDA remained unchanged. In vivo oxidation treatments elicited immediate and significant increases in GSSG and PSSG over basal values (up to 200-fold), whereas PCO and MDA showed only slight variation 120 or 180 min after treatment. Conclusions: With the use of artifact-free measurement methods, GSH, GSSG, and PSSG are potentially powerful and reliable biomarkers of oxidative stress status and can be used to evaluate whether, and to what extent, oxidative stress may be involved in various diseases.

Continuous In-Vivo Estimation of Blood Alcohol

1962 ◽  
Vol 8 (1) ◽  
pp. 72-79 ◽  
Author(s):  
Guy Nadeau ◽  
Benoit Fortin ◽  
Pierre Dugal
Keyword(s):  
Blood Glucose ◽  
Chemical Analysis ◽  
Preliminary Data ◽  
Blood Collection ◽  
Blood Alcohol ◽  
In Vivo Experiments ◽  
Alcohol Water ◽  
Saline Solutions

Abstract Automated chemical analysis was applied to constant in-vivo experiments on dogs for the determination of blood alcohol. The continuous blood collection was similar to that in earlier experiments for determination of blood glucose in humans. Although interferences by glucose was observed in the chemical methodology used, preliminary data show that the rise of blood alcohol is slower following I.V. administration of alcohol-water mixtures than with alcohol-saline solutions. With the experimental animal under pentobarbital anesthesia, the alcohol equilibrium is reached more rapidly and the elimination period is significantly prolonged.

STEROID METABOLISM IN THE PERFUSED HUMAN PLACENTA

1978 ◽  
Vol 87 (1) ◽  
pp. 181-191 ◽  
Author(s):  
Alfred S. Wolf ◽  
Klaus A. Musch ◽  
Werner Speidel ◽  
Jürgen R. Strecker ◽  
Christian Lauritzen
Keyword(s):  
Venous Blood ◽  
Placental Lactogen ◽  
Dehydroepiandrosterone Sulphate ◽  
Metabolic Capacity ◽  
Loading Test ◽  
Lower Range ◽  
Group I ◽  
High Concentrations ◽  
Steroid Precursor

ABSTRACT A new model for the perfusion of human term-placentas has been developed for studies on the placental biogenesis of C-18 and C-19 steroids. For viability criteria, the glucose- and oxygen-consumption, regional perfusion control by dye-infusions or scanning after injection of 99Tc-labelled macroparticles, and the histological qualification were chosen. The recycled perfusate was investigated for the steroids oestrone (Oe1), oestradiol-17β (Oe2), oestriol (Oe3), 4-androstene-3,17-dione (A), testosterone (T), and human placental lactogen (HPL) by radioimmunoassay in controls and perfusions with the foetal steroid precursor dehydroepiandrosterone sulphate (DHA-S). In control perfusions, steroid hormones were found in constant ratios (Oe1:Oe2:Oe3:T:A = 30:1.5:100:0.35:1). Following the administration of 10 mg DHA-S for testing the metabolic capacity of the organ, high concentrations of Oe1 (90–720 ng/ml = 250–3970 % as compared to 100% pre-injection values) were found, shortly preceded by a rapid increase of A (66–1000 ng/ml = 100–16 000 %). A typical surge of T (5.3–147 ng/ml = 265–4640 %) preceded the normally slower increment of Oe2 (22–220 ng/ml = 1570–4330 %). The concentrations of Oe3 and HPL remained nearly unchanged. From different steroid patterns after DHA-S-load, two distinct responses of term-placentas could be differentiated: Group I (n=12) showed high concentrations of Oe1 (3200 ± 940 %), a small increase of T (1020 ± 500%), as well as low and delayed values of Oe2 (1660 ± 450%). In Group II (n = 5), values were high for T (3160 ± 1020%) and Oe2 (3300 ± 1110%), whereas Oe1 was found in a lower range (508 ± 302%). In contrast to in vivo findings in maternal venous blood after DHS-S injection to the mother, oestrone was found in perfusions as the main oestrogen fraction from DHA-S. Thus, the analysis of such metabolic differences might be of help in the interpretation of complex results from the DHA-S-loading test.

Stem Cell Cure for Kidney Injury: Therapy to Solve Most Complex Issues in Renal System

2020 ◽  
Author(s):  
Prithiv K R Kumar
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Kidney Injury ◽  
Cell Types ◽  
Tissue Remodelling ◽  
Major Health Problem ◽  
In Vivo Experiments ◽  
Renal Regeneration ◽  
Induced Pluripotent

Renal failure is a major health problem. The mortality rate remain high despite of several therapies. The most complex of the renal issues are solved through stem cells. In this review, different mechanism for cure of chronic kidney injury along with cell engraftment incorporated into renal structures will be analysed. Paracrine activities of embryonic or induced Pluripotent stem cells are explored on the basis of stem cell-induced kidney regeneration. Several experiments have been conducted to advance stem cells to ensure the restoration of renal functions. More vigour and organised protocols for delivering stem cells is a possibility for advancement in treatment of renal disease. Also there is a need for pressing therapies to replicate the tissue remodelling and cellular repair processes suitable for renal organs. Stem cells are the undifferentiated cells that have the ability to multiply into several cell types. In vivo experiments on animal’s stem cells have shown significant improvements in the renal regeneration and functions of organs. Nevertheless more studies show several improvements in the kidney repair due to stem cell regeneration.

In vivo Experiments of Natural Products Protection of Antagonistic Effects of Lead on Iron

2018 ◽  
Vol 68 (12) ◽  
pp. 2747-2751
Author(s):  
Marioara Nicula ◽  
Nicolae Pacala ◽  
Lavinia Stef ◽  
Ioan Pet ◽  
Dorel Dronca ◽  
...  
Keyword(s):  
Aquatic Environment ◽  
Iron Homeostasis ◽  
Iron Concentration ◽  
Antagonistic Effect ◽  
Tissue Samples ◽  
Antagonistic Effects ◽  
In Vivo Experiments ◽  
Living Organisms ◽  
Toxic Potential

Living organisms take nutrients from the environment, and together with them, substances with toxic potential � such as heavy metals. Lead is one common metal pollutant especially in aquatic environment, from where the fish can be intoxicated very easily. Bioavailability, distribution, toxic action, synergistic and antagonistic effects are characteristics which can alter the fish health. Our experimental study followed the effects of lead overload in water on iron distribution, in different tissues sample Carassius gibelio Bloch fish. We performed the experiment in four different fish groups: control C; lead � Pb (administration of lead in water 0.075mg/mL of water, as Pb(NO3)2 x � H2O); lead (the same dose) and 2% of freeze-dry garlic incorporated into fishes� food � Pb+garlic; lead (the same dose) and 2% chlorella incorporated into fishes� food � Pb+chlorella, for 21 consecutive days. The iron concentration was analysed with AAS (Atomic Absorption Spectroscopy) from gills, muscle, skin (and scales), intestine, liver, heart, brain, ovary, testicles, and kidney. The obtained data presented a significantly decrease of iron content in all tested tissue samples that demonstrated, alteration of iron homeostasis, explained by a strong antagonistic effect of lead on iron. Our experiment showed that biologic active principles from garlic and chlorella act like natural protectors, and potentiate the iron deficiency even in the case of lead overload in aquatic environment, for fish.

Sign in / Sign up

Export Citation Format

Share Document